LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 22 Jan 2026
Drug Safety Update

Isotretinoin

Published on 22 Jan 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare…
Drug Safety Update on GOV.UK ↗ All events: Isotretinoin

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice.

Other events for Isotretinoin

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.